Yingfei Fan "Settled" in Xinhua Pharmacy
Release time:
2020-07-15
The number of designated charity drug donation varieties in Jinqu region has reached 16
. Recently, the first PD-L1 immunotherapy drug duvalizumab (Yingfeifan) approved for listing in China has officially started to be sold. Xinhua Pharmacy, the peak pharmacy, has become the only designated pharmacy in Yingfeifan in Jinqu region and is also the designated service point for charity drug donation in Yingfeifan. On March 27, Xinhua Pharmacy completed the first sale of Yingfeifan, which was delivered to patients by licensed pharmacists in the pharmacy.
Infeifan was formally approved by the National Drug Administration (NMPA) in December 2019 for the treatment of patients with unresectable, stage III non-small cell lung cancer (NSCLC) who have not progressed after receiving platinum-based chemotherapy and concurrent radiotherapy. The results of phase III PACIFIC clinical trials show that the use of Imfinzi immunotherapy after concurrent radiotherapy and chemotherapy reduces the risk of death by nearly 32% in patients with stage III inoperable NSCLC. The median progression-free survival (PFS) is 16.8 months, and the 3-year overall survival rate (OS) is as high as 57%. Infineon is the first PD-L1 immunosuppressant approved for the treatment of stage III lung cancer in mainland China. The approval marks a new era of immunotherapy for unresectable stage III non-small cell lung cancer in China.
In order to improve the accessibility and standardization of lung cancer immunotherapy for lung cancer patients, reduce the economic burden of patients and prolong the life of patients. The China Primary Health Care Foundation officially launched the "Aifan-Lung Cancer Immunotherapy Patient Assistance Project" on February 29. Patients with low-income insurance who meet the indications for the treatment of duvalizumab can receive free charity drugs until the disease progresses. In the first round, patients can get 2 courses of drug assistance free of charge after using 2 courses of duvalizumab at their own expense; in the second round, patients can get 4 courses of drug assistance free of charge after using 4 courses of duvalizumab at their own expense; in the third round, patients can get 8 courses of free drug assistance after using 6 courses of duvalizumab at their own expense, under the premise that the disease does not progress, the subsequent application for drug donation can be circulated. After investigation and evaluation in various aspects, Xinhua Pharmacy has become a designated service point for charity drug donation in Yingfeifan in Jinliqu area.
Xinhua Pharmacy is a designated pharmacy for serious illness medical insurance in Jinhua City, with complete drug equipment. All hardware facilities are perfect. For drugs that need to be refrigerated, pharmacies have special refrigerators for storage. The refrigerators are equipped with monitoring probes, which are connected to the mobile phone system. If the temperature is abnormal, SMS alarm will be issued. At the same time, Xinhua Pharmacy is also equipped with special personnel to provide drug donation services, which have previously been identified as designated service points for charity drug donation of many varieties such as Terrisa, Iressa, Gnico, Herceptin and Libitai. After Yingfeifan "settled down", there are 16 varieties of designated charity drugs in Jinqu area of Xinhua drugstore. (Reporter Ni Yingzhen)
More information
On the afternoon of June 9, Peak Cable Company organized all employees to learn fire fighting knowledge and conducted fire fighting and emergency escape drills. Since June, the subordinate enterprises of the company have organized training, learning and drills related to production safety according to their own characteristics and combined with the actual work. Safety production month series of activities carried out in an orderly manner.
2022
06-13
Spike Postdoctoral Research Papers on International Frontier Journals
Recently, good news came from the postdoctoral workstation of Jianfeng Pharmaceutical. Under the guidance of workstation mentor Jiang Xiaomeng, associate researcher Yang Xiaoxiao has made new progress in the treatment of alcoholic liver disease. The relevant research results "Roxadustat, a hypoxia-inducible factor 1a activator, attenuates both long- and short-term alcohol induced alcoholic liver disease" were published in the internationally renowned academic journal "Frontiers in Pharmacology. This journal is a frontier journal in the field of international pharmacy, mainly publishing academic papers and information on basic and clinical pharmacology, medicinal chemistry, pharmacology and toxicology.
2022
06-01
Daye Peak QC Achievements Won the Third Prize of Huangshi City
On May 7, Huangshi City Quality Strong City Working Committee organized a 2022 QC Results Conference. The QC project of "Technical Transformation of Ore Limestone Batching System" of Daye Peak Cement Company won the third prize.
2022
06-01
On April 28, Dalian Commodity Exchange held an online working meeting to announce the results of the 2021 excellent delivery warehouse and delivery warehouse excellent futures personnel selection, peak international trading company won the 2021 "excellent designated delivery warehouse" title, futures commissioner Ruan Weihang won the "excellent futures personnel" title.
2022
06-01
Cranberry extract combination identification detection method won the invention patent
After cranberry extract products were included in the "Zhejiang Province Key High-tech Product Development Project Plan" in 2021, Jianfeng Health Technology Company recently obtained an invention patent for the identification and detection method of cranberry extract. This new combined identification and detection method developed by Jianfeng Health identifies whether catechin or procyanidin B2 is added in cranberry extract by thin layer analysis, and then detects the unique A- type procyanidin and its chromatographic distribution in cranberry extract by high performance liquid chromatography, so as to improve the accuracy of product judgment. The identification method has the characteristics of accurate results and short detection time, which is of great significance to standardize the cranberry extract market and promote the healthy development of the industry, and has been unanimously recognized by peers.
2022
05-20
Daye Peak Manufacturing Department Won the Title of "Worker Pioneer" in Hubei Province
A few days ago, the manufacturing department of Daye Peak Cement Company was awarded the title of "Worker Pioneer" by the Hubei Provincial Federation of Trade Unions. Daye Jianfeng Manufacturing Department not only continued to actively explore and achieved good results in energy saving and consumption reduction, technological transformation, product quality process control, and economic responsibility system to guide management, but also improved Daye Jianfeng's overall operation level and won Huangshi City The seventh "Mayor Quality Award" created conditions and was fully affirmed by government departments at all levels.
2022
05-20
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page